1. Home
  2. GMED vs ASND Comparison

GMED vs ASND Comparison

Compare GMED & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$93.63

Market Cap

11.7B

Sector

Health Care

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$206.23

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMED
ASND
Founded
2003
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.7B
12.8B
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
GMED
ASND
Price
$93.63
$206.23
Analyst Decision
Buy
Strong Buy
Analyst Count
15
16
Target Price
$95.92
$262.38
AVG Volume (30 Days)
1.5M
618.3K
Earning Date
02-24-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
358.86
N/A
EPS
3.08
N/A
Revenue
$2,769,804,000.00
$758,592,045.00
Revenue This Year
$17.65
$99.54
Revenue Next Year
$8.37
$84.40
P/E Ratio
$30.35
N/A
Revenue Growth
11.75
97.46
52 Week Low
$51.79
$118.03
52 Week High
$101.40
$229.94

Technical Indicators

Market Signals
Indicator
GMED
ASND
Relative Strength Index (RSI) 60.43 46.61
Support Level $88.59 $188.08
Resistance Level $101.40 $221.75
Average True Range (ATR) 3.00 10.08
MACD 0.03 -0.09
Stochastic Oscillator 51.82 53.52

Price Performance

Historical Comparison
GMED
ASND

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: